Pneumovax-23康肺苗

Pneumovax-23

vaccine, pneumococcal

Manufacturer:

MSD

Distributor:

Zuellig
Concise Prescribing Info
Contents
Pneumococcal vaccine, polyvalent
Indications/Uses
Vaccination against pneumococcal disease caused by those pneumococcal types included in the vaccine in selected individuals age ≥2 yr w/ chronic CV disease, chronic pulmonary disease or DM, w/ alcoholism, chronic liver disease or CSF leaks, w/ functional or anatomic asplenia, living in special environments or social settings, w/ HIV infection, leukemia, lymphoma, Hodgkin's disease, multiple myeloma, generalized malignancy, chronic renal failure or nephrotic syndrome; those receiving immunosuppressive therapy, organ or bone marrow transplant; routine vaccination for persons ≥50 yr of age.
Dosage/Direction for Use
Single 0.5 mL dose SC/IM (preferably in the deltoid muscle or lateral mid-thigh).
Special Precautions
In persons receiving immunosuppressive therapy, expected serum Ab response may not be obtained & may impair future immune response to pneumococcal antigens. Avoid IV or intradermal administration. Individuals w/ severely compromised CV &/or pulmonary function. Delay usage in febrile resp illness or other active infection. In patients requiring antibiotic prophylaxis against pneumococcal infection, such prophylaxis should not be discontinued after vaccination. Pregnancy & lactation. Elderly. Not recommended for use in childn <2 yr.
Adverse Reactions
Fever, inj site reactions including soreness, erythema, warmth, swelling & local induration.
ATC Classification
J07AL01 - pneumococcus, purified polysaccharides antigen ; Belongs to the class of pneumococcal bacterial vaccines.
Presentation/Packing
Form
Pneumovax-23 vaccine (inj) 0.5 mL
Packing/Price
1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in